Radionuclide Therapy May Enhance Cancer Cell Death Pathways

from TheBrief.Health · host TheBrief.Health

Radionuclide-stimulated dynamic therapy activates light-sensitive drugs with radiopharmaceuticals to produce cancer-killing reactive oxygen species, reprogram tumor immunity, and overcome resistance in aggressive cancers.

Episode metadata supplied by the publisher feed · Published Mar 12, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Radionuclide Therapy May Enhance Cancer Cell Death Pathways

0:00 1:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on March 12, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!